TP53 and neoplasm: In aggreement with several studies showing that PUMA controls caspase-3 activation associated to ischemia in cardiomyocytes and tumor cells38,39, we found that NMDA-PC prevents ischemia-induced activation of the p53/PUMA/caspase-3 signaling pathway and promotes neuroprotection against a subsequent ischemic damage.